| Medical and Health Sciences | 2021-2025 | 132 | DE 6 | 99.98 |
| Surgery | Lifetime | 838 | DE 36 | 99.20 |
| Hepatology | Lifetime | 126 | DE 7 | 99.14 |
| Oncology | Lifetime | 925 | DE 39 | 97.95 |
| Surgery | 2021-2025 | 26 | DE 1 | 99.85 |
| Hepatology | 2021-2025 | 6 | DE 1 | 99.83 |
| Oncology | 2021-2025 | 99 | DE 8 | 99.40 |
| Epidemiology | 2021-2025 | 376 | DE 15 | 96.86 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 298 | DE 12 | 97.27 |
| Cancer Research | 2021-2025 | 301 | DE 17 | 82.67 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 61 | DE 1 | 99.58 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 83 | DE 3 | 99.61 |
| Cancer Mechanisms and Therapy | Lifetime | 76 | DE 5 | 99.01 |
| Liver Disease Diagnosis and Treatment | Lifetime | 590 | DE 43 | 99.22 |
| Gallbladder and Bile Duct Disorders | Lifetime | 177 | DE 11 | 99.05 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 407 | DE 30 | 98.93 |
| Pediatric Hepatobiliary Diseases and Treatments | Lifetime | 243 | DE 15 | 98.47 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 877 | DE 52 | 98.20 |
| Colorectal Cancer Treatments and Studies | Lifetime | 640 | DE 25 | 98.13 |
| Liver physiology and pathology | Lifetime | 361 | DE 33 | 96.97 |
| Liver Diseases and Immunity | Lifetime | 320 | DE 25 | 97.52 |
| Ferroptosis and cancer prognosis | Lifetime | 839 | DE 21 | 93.08 |
| Fibroblast Growth Factor Research | Lifetime | 564 | DE 25 | 93.35 |
| Chromatin Remodeling and Cancer | Lifetime | 852 | DE 79 | 84.23 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 1 | DE 1 | 99.93 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 3 | DE 1 | 99.93 |
| Cancer Mechanisms and Therapy | 2021-2025 | 3 | DE 1 | 99.56 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 20 | DE 2 | 99.61 |
| Gallbladder and Bile Duct Disorders | 2021-2025 | 20 | DE 1 | 99.18 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 194 | DE 11 | 99.01 |
| Pediatric Hepatobiliary Diseases and Treatments | 2021-2025 | 37 | DE 2 | 97.92 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 325 | DE 10 | 98.73 |
| Cancer Genomics and Diagnostics | 2021-2025 | 273 | DE 18 | 97.96 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 166 | DE 6 | 97.81 |
| Fibroblast Growth Factor Research | 2021-2025 | 25 | DE 1 | 95.02 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 143 | DE 6 | 95.36 |
| Peptidase Inhibition and Analysis | 2021-2025 | 231 | DE 28 | 95.08 |
| Hepatitis B Virus Studies | 2021-2025 | 221 | DE 12 | 96.00 |
| Renal cell carcinoma treatment | 2021-2025 | 257 | DE 10 | 95.79 |
| Hepatitis C virus research | 2021-2025 | 277 | DE 16 | 95.39 |
| Liver physiology and pathology | 2021-2025 | 176 | DE 10 | 87.46 |
| Chromatin Remodeling and Cancer | 2021-2025 | 208 | DE 38 | 78.94 |
| Ocular Oncology and Treatments | 2021-2025 | 560 | DE 56 | 73.13 |
